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Myocardial thallium-201 scintigraphy is being increas-
ingly employed as a method for assessing the efficacy of
coronary reperfusion in acute myocardial infarction. New
thallium uptake after intracoronary tracer administra-
tion after successful recanalization indicates that nu-
trient blood flow has been successfullyrestored. One may
also presume that some myocardial salvage occurred if
thallium administered in this manner is transported in-
tracellularly by myocytes with intact sarcolemmal mem-
branes. However, if one injects thallium by way of the
intracoronary route immediately after reperfusion, the
initial uptake of thallium in reperfused myocardium may
predominantly represent hyperemic flow and regional
thallium counts measured may not be proportional to
the mass of viable myocytes. When thallium is injected
intravenously during the occlusion phase the degree of
redistribution after thrombolysis is proportional to the
degree of flow restoration and myocardial viability. When
thallium is injected for the first time intravenously im-
mediately after reperfusion, an overestimation of myo-
Myocardial thallium-201 scintigraphy is being increasingly
employed as a noninvasive method for the assessment of
myocardial ischemia and infarction. The initial distribution
of thallium-20 I after intravenous injection is dependent on
regional myocardial blood flow and the myocardial extrac-
tion fraction for thallium (1,2). Delayed redistribution of
thallium-201 in a myocardial region over 2 to 4 hours after
*Part [ and II of this Seminar appeared in the November 1986 and
January 1987 issues of the Journal.
From the Cardiology Division. Department of Internal Medicine. Uni-
versity of Virginia Medical Center, Charlottesville, Virginia. This work
was supported in part by Grant HL-26205 from the National Heart, Lung.
and Blood Institute, National Institute, of Health. Bethesda. Maryland.
Manuscript received June 2, 1986; revised manuscript received Sep-
tember 10, 1986. accepted October 10. 1986.
Address for reprints: George A. Beller, MD, Cardiology Division, Box
158, University of Virginia Medical Center. Charlottesville. Virginia 22908.
«: 19H7 by the American College 01 Cardiology
cardial salvage may occur because of "excess" thallium
uptake in the infarct zone consequent to significant hy-
peremia. Another approach to myocardial thallium scin-
tigraphy in patients undergoing thrombolytic therapy is
to administer two separate intravenous injections before
and 24 hours or later after treatment. Clinical studies
have demonstrated that the improvement in defect size
on serial images predicts improvement in regional func-
tion and patency of the infarct-related vessel.
Finally, patients with acute myocardial infarction who
receive intravenous thrombolytic therapy are candidates
for predischarge exercise thallium-201 scintigraphy for
risk stratification and detection of residual ischemia. Pa-
tients demonstrating thallium redistribution in the zone
of the infarct-related vesselor multiple defects within or
remote from the infarct region would be candidates for
revascularization to reduce the incidence of subsequent
ischemic events.
(J Am Coll Cardiol 1987;9:661-8)
tracer administration has been thought to be a reflection of
underperfused but viable myocardium (3). In contrast, a
severe defect in thallium uptake that remains persistent over
the serial imaging period is indicative of irreversibly injured
myocardium due to acute necrosis or previous scar. With
the recent availability of thrombolytic agents for clinical
use, several groups have begun to employ exercise or rest
thallium scintigraphy to assess the extent of reflow and
salvage after coronary reperfusion. The mode and timing
of thallium administration during thrombolytic therapy and
the technique of analyzing early and late myocardial thal-
lium activity have varied considerably in both experimental
and clinical protocols when used for assessing the efficacy
of coronary reperfusion.
In this review, uptake and washout kinetics of thallium-
20 I in experimental models of coronary reperfusion will be
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reviewed and the clinical studies utilizing either intracoro-
nary or intravenous thallium administration before and after
thrombolytic therapy will be summarized. Limitations of
this technique will also be reviewed and directions for the
future of perfusion imaging in this setting will be recom-
mended.
Intracoronary Thallium-20t Imaging
Previous studies. Several groups of investigators have
obtained scintigrams after intracoronary thallium adminis-
tration before and after intracoronary streptokinase infusion.
Maddahi et al. (4) showed that immediate postreperfusion
intracoronary thallium images in dogs undergoing prolonged
experimental coronary occlusion revealed absence of myo-
cardial uptake in previously occluded zones. Failure of intra-
coronary thallium uptake correlated with presence of ne-
crosis as demonstrated by histochemical staining. In contrast,
in dogs undergoing an average of approximately 30 minutes
of coronary occlusion, reperfused myocardium showed nor-
mal thallium uptake after intracoronary injection. These in-
vestigators also showed that when thallium was injected into
the reopened coronary artery in patients, normal or improved
thallium uptake in reperfused myocardium was observed in
two patients with a mean time of 21/ 2 hours from symptom
onset to reperfusion. This correlated with late recovery of
segmental function. In contrast, in three other patients in
this study the time from symptom onset to reperfusion was
5 hours. Immediate postreperfusion intracoronary thallium
images did not show improvement, correlating with persis-
tence of wall motion abnormalities 10 days later.
Markis et al. (5) performed intracoronary thallium-20 I
imaging before and after streptokinase infusion in nine pa-
tients with acute myocardial infarction. These investigators
showed that lysis of the coronary thrombus was followed
by restoration of thallium-201 uptake toward normal in the
distribution of the occluded vessel. Worsening of a thallium-
20 I defect on repeat imaging was reported to be coincident
with reocclusion in one of the patients. In most patients
studied at 2 weeks to 3 months after streptokinase therapy,
repeat intracoronary thallium-20 I scans were not different
from those obtained 1.5 hours after reperfusion.
More recently, Schofer et al. (6) performed dual isotope
scintigraphic studies with thallium-201 and technetium-99m
microalbumin (aggregates) in 12 patients with acute myo-
cardial infarction undergoing intracoronary thrombolysis.
Before therapy, intracoronary thallium-20l and technetium-
99m aggregates scintigraphy resulted in identically sized
thallium-Xll and technetium-99m defects. Immediately after
intracoronary thrombolysis most patients showed a concor-
dant improvement or lack of improvement in defect size
with the two agents. In all but one patient the thallium and
technetium-99m defect sizes were comparable after reper-
fusion. One of the 12 patients showed a significant im-
provement in the technetium defect but only a minor change
in the thallium defect size after thrombolysis. At 2 to 4
weeks after thrombolysis, seven of eight patients restudied
had thallium-201 and technetium-99m defect sizes that were
identical with those observed immediately after thrombol-
ysis. The results of this study showed that absence of new
thallium uptake after angiographically successful intracor-
onary thrombolysis reflects lack of capillary reperfusion,
suggesting that the "no reflow" phenomenon can be de-
tected in humans.
In another study by Schofer et al. (7), intracoronary thal-
lium-20l and intracoronary technetium-99m pyrophosphate
images were obtained before and 30 to 60 minutes after
thrombolysis. The regional ejection fraction as determined
by contrast ventriculographic techniques improved in pa-
tients showing substantial new thallium uptake after throm-
bolysis. In patients with a lesser or no improvement in
regional function, a large residual defect was observed after
thrombolysis, and in certain instances technetium-99m py-
rophosphate accumulation was observed in the area of new
thallium uptake. In the instances of permanent coronary
occlusion in which thrombolysis failed, no changes in thal-
lium defect size or regional ejection fraction were observed
and no technetium-99m pyrophosphate accumulation was
seen.
Significance of new thallium uptake or persistent de-
fect after intracoronary thallium administration. The
results of these studies indicate that new thallium uptake
after intracoronary tracer administration after successful re-
canalization indicates that nutrient blood flow has been suc-
cessfully restored. One may also presume that some myo-
cardial salvage occurred if thallium administered in this
manner is transported intracellularly by myocytes with intact
sarcolemmal membranes. The observation that new thallium
uptake predicts subsequent improvement in regional wall
motion supports this contention. However, if one injects
thallium by the intracoronary route immediately after re-
perfusion, the initial uptake of thallium in reperfused myo-
cardium may predominantly represent hyperemic flow and
the regional thallium counts measured may not be propor-
tional to the mass of viable myocytes. An overestimation
of myocardial salvage will be interpreted from this initial
image. If one imaged over time after intracoronary thallium
injection in this situation one might see rapid washout of
unextracted tracer yielding a residual defect only on a de-
layed image. Despite these theoretical limitations, it is clear
that when one sees a significant residual defect with intra-
coronary thallium administration soon after thrombolytic
therapy it is predictive of failure to accomplish an enhance-
ment in regional perfusion. Most patients in the studies cited
with no early improvement showed no late improvement at
10 days to 3 months, which supports this view. If the defect
observed after successful anatomic reperfusion represented
"stunned" membrane function, improvement in thallium
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uptake several weeks to months later should be observed.
This improvement has not yet been demonstrated in such
instances.
Figure 1. Myocardial thallium-20l (TI-20 I) time-activity curves
in eight dogs undergoing I hour of left anterior descending (LAD)
coronary artery occlusion and rapid reperfusion through a totally
patent vessel. Thallium-201 was administered during occlusion.
(Reprinted by permission of theAmerican Heart Association, Inc.
from Granato et al. [9).)
Intravenous Thallium Redistribution Imaging
Experimental studies. As previously mentioned, the
initial uptake of thallium after intravenous injection is re-
lated to regional myocardial blood flow whereas the delayed
thallium distribution (redistribution) is a marker of cell vi-
ability. Khaw et al. (8) showed that delayed thallium dis-
tribution was inversely related to uptake of iodine-125 la-
beled Fab fragments of antimyosin antibody. The antibody
is presumably only bound to necrotic myocytes with myosin
subunits exposed to the capillary circulation. We (9) per-
formed experiments in which thallium-20I wasadministered
intravenously to anesthetized dogs after 1 hour or 3 hours
of left anterior descending coronary artery occlusion. Thal-
lium activity was quantitated during the occlusion phase and
serially after reperfusion. We found that the degree of re-
distribution in the reperfused zone correlated with the degree
of myocardial salvage as assessed by regional flow values
and histochemical staining. Figure I shows myocardium
thallium time-activity curves from normal and reperfused
myocardial regions in a representative dog undergoing I
hour of left anterior descending artery occlusion before re-
flow. Partial redistribution is evident after 2 hours of reflow.
In animals receiving thallium-20l during a sustained 3 hour
occlusion, without reperfusion, there was no significantde-
layed accumulation of thallium in the zone of the occluded
artery. In another group of animals, thallium was admin-
istered for the first time soon after reperfusion rather than
during the I hour of occlusion. With this method of thallium
administration, the degree of myocardial salvage was over-
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estimated because excess thallium uptake was measured in
the infarct zone secondary to hyperemia at the time of thal-
lium administration (Fig. 2). Measurement of thallium ac-
tivities over time revealed a more rapid washout of thallium
from the infarcted region than from normal myocardium.
The final defect size 2 hours after reperfusion in dogs re-
ceiving thallium soon after reperfusion was significantly
smaller than the defect size observed in dogs receiving thal-
lium during occlusion, before reperfusion, in which redis-
tribution was assessed (Fig. 2 versus Fig. I). However,
comparable degrees of necrosis were observed in the two
groups. These findings indicate that differing thallium up-
take and washout patterns will be observed depending on
the mode and timing of thallium administration. Thallium
given immediately after reflow may become "trapped" in
the infarct zone yielding a smaller defect than expected from
the degree of necrosis seen histologically.
Forman and Kirk (10) administered thallium-20I intra-
venouslyearly and late after reperfusion in open chest dogs.
They also showed that the immediate thallium distribution
was related more to myocardial blood flow than to cellular
viability. When thallium was given 24 hours after reper-
fusion, thallium uptake relative to flow was significantly
less than that observed when thallium was given soon after
reperfusion. As in our study, they showed that when there
was significant hyperemia soon after reperfusion, the thal-
lium uptake in the zone of necrosis was similar to that seen
in the normal zone. Accumulation of thallium in the sub-
Figure 2. Myocardial thallium-201 (TI-20 I) time-activity curves
in 10 dogs undergoing I hour of left anterior descending (LAD)
coronary artery occlusion followed by rapid reperfusion through
a totally patent vessel. Thallium-201 was administered at peak
reflow. Note the "excess" thallium uptake in thereperfused zone
and thesubsequent early rapid washout component. (Reprinted by
permission of theAmerican Heart Association, Inc. from Granato
et al. [91.)
180120
Group no
(n ~ B)
x Normal Biopsy
X~T • Ischemic Biopsy
l~
~ 1
60
t
TI-201 Reflow
Time (minutes post Occlusion)
t
LAD
Occlusion
00
-= 100
o
E
<5 80
z
~
.~ 60
>
fj 40
<l
~ 20
I
664 BELLER
MYOCARDIAL IMAGING ANDTHROMBOLYTIC THERAPY
JACC Vol. 9. No.3
March 1987:661-8
endocardium or subepicardium, which was a function of
flow at the time of injection, was independent of whether
the subendocardium was frankly infarcted or destined to
become necrotic. These experimental results again empha-
size that timing of thallium administration after coronary
flow restoration will greatly influence uptake and washout
patterns. Melin et al. (II) reported similar findings in that
thallium uptake 20 minutes after reperfusion, preceded by
3 hours of coronaryocclusion, was often more than 50lk of
normal in reperfused necrotic regions because of persis-
tent hyperemic flow at the time of thallium administration.
Okada (12) studied the kinetics of thallium-20 I in an
experimental myocardial infarction model. Thallium activ-
ity was monitored for 4 hours in reperfused and normal
myocardial regions using miniature radiation detectors. After
coronary artery reperfusion, thallium cleared faster from
nonsalvaged acutely infarcted myocardium compared with
salvagednoninfarcted myocardium. Aftera rapidearly thal-
lium clearance phase, the subsequent exponential clearance
from the necrotic region paralleled the clearance from sal-
vaged myocardium and from normal myocardium. Okada
and Pohost (13) employed a method of sequential admin-
istration of thallium-20 I during occlusion and reperfusion
with subtraction of the images by computer processing.
Thallium scans obtained shortly after reperfusion failed to
delineate defects that were apparent on repeat scintigraphy
48 hours later. This is because the immediate postreperfu-
sion thallium images demonstrated excess thallium uptake
due to the hyperemic flow consequent to release of the
coronary ligature. Our findings are similar in this regard in
that there was an excess thallium uptake in the reperfused
infarcted regionsecondary to hyperemia followed by a rapid
early washout phase.
The implication ofthese experimental studies for clinical
imaging after thrombolytic therapy is that when thallium is
administered for the first time after reperfusion it should
probably not be injected immediately after flow restoration
when hyperemia may exist. In all the experimental studies
summarized here, the magnitude of thallium uptake in re-
perfused myocardium wasgreaterthanexpectedfrompatho-
logic postmortem examination. On the other hand, a better
assessment of myocardial salvage seemed to be achieved
when redistribution was monitored and thallium adminis-
tered during the occlusion phase just before reflow.
Clinical thaJlium-201 scintigraphy. Redistribution im-
aging at rest with intravenous thallium administration has
been used to evaluate efficacy of coronary reperfusion with
thrombolytic therapy in patients with acute myocardial in-
farction. The laboratory work summarized here provides
experimental validation of the methods of previous inves-
tigators (14-16) who administered thallium-201 intrave-
nously and obtainedprethrombolysis images. Redistribution
images were subsequently obtained after streptokinase in-
fusion . Each of these studies showed that patients demon-
strating successful thrombolysis had more thallium redis-
tribution and a smaller final thallium defect size compared
withthescanfindings inpatients witha persistently occluded
vessel.
Simoons et al. (IS) performed pre- and 3 hour post-
streptokinase thallium-201 scintigrams in 50 patients and
observed some degree of delayed thallium redistribution in
43 patients. Redistribution was significantly greater in pa-
tients with open or recanalized arteries (35 ± 24 versus
17 ± 12% of initial defect). Reduto et al. (14) reported
that in instances in which myocardial salvagedid not occur,
a persistent defect in the infarct region was observed on the
delayed image, whereas in patients in whom reperfusion
was considered successful, delayed redistribution with in-
creased relative thallium uptake in the infarct zone was
observed. The improvement of thallium uptake on redistri-
bution images correlatedwell withsubsequent improvement
in left ventricular ejection fraction at rest.
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Figure 3. Mean values ( ± SEM) of sequential
thallium defect scores before intracoronary
streptokinase therapy in acute myocardial in-
farction (PRE ANGlO), 4 hours after strepto-
kinase (4 HR RDST) and 4 days and 6 weeks.
Left, Patients without reperfusion ; right, pa-
tients with reperfusion . A serial improvement in
thallium defect score is noted from 4 hours to 6
weeks after successful reperfusion . (Reprinted
with permission from DeCoster et al. [16].)
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zation, the size of the perfusion defect decreased from 36
to 19% of the left ventricular circumference at 24 hours.
No significant change was detected by redistribution at 1
hour in these patients. In patients with a persistently oc-
cluded vessel, the thallium defect size was unchanged at 1
hour and 24 hours after intracoronary streptokinase admin-
istration. The thallium defect size was most decreased in
patients with extensive collateral vessels supplying the isch-
emic area.
In the Western Washington Intracoronary Streptokinase
in Myocardial Infarction Trial, Ritchie et al. (20) performed
quantitative single photon emission computed tomography
(SPECT) thallium-20l rest imaging in 100 patients 8 weeks
after treatment. They found no difference in thallium defect
size between 48 control and 52 streptokinase-treated pa-
tients. However, the 30 day mortality rate was lower in
patients receiving thrombolytic treatment. They also found
no difference in global or regional ejection fraction in the
two groups. In that study there was no relation between
radionuclide measures of perfusion and function and vessel
patency. However, the time to vessel opening approximated
5 hours in that trial. These results emphasize that when
reftow is accomplished late after the onset of infarction, one
cannot expect significant salvage. The explanation for the
Figure 4. A, Potential approaches to management of postmyo-
cardial infarctionpatientswithsinglevessel coronaryarterydisease
(CAD) who have undergone predischarge exercise thallium-2ot
(TI-20I) scintigraphy. B, Potential approaches to management of
patients undergoing thrombolytic therapy who have multivessel
coronary artery disease (CAD) and have undergone predischarge
exercise thallium-201 scintigraphy. ASA = aspirin; LAD = left
anterior descending artery; PTCA = percutaneous transluminal
coronary angioplasty; Rx = treatment.
Angiography: Single VesselCAD
~
• TI-201 redistribution • Persistent TI-201 defect
• Open infarct vessel • Occluded or open
M infarct vessel• AkinesislQi]
DeCoster et al. (16) demonstrated an increase in thallium
uptake in 4 hour redistribution images in patients with proved
coronary artery reperfusion who underwent streptokinase
therapy. Additionally, their study showed that in the group
in whom reperfusion was achieved, a further improvement
in thallium uptake was seen at 4 days and 6 weeks when
imaging was repeated (Fig. 3). This late improvement was
observed both in the control and streptokinase groups but
only in the reperfused patients in these groups.
There are some limitations to the use of redistribution
imaging in evaluation of patients receiving thrombolytic
therapy. The time that it takes to obtain pretreatment images
may delay for up to 20 or 30 minutes the institution of
therapy. This may be detrimental because the earlier that
reperfusion can be accomplished the more chance there is
for myocardial salvage. On the other hand, if thallium is
administered for the first time immediately after reperfusion,
the degree of salvage could be overestimated because the
tracer is being injected during hyperemia. Also, some per-
sistent defects represent no irreversibly injured myocardium
but severe ischemia (17). These patients might benefit from
further revascularization, but they are difficult to differen-
tiate by thallium scintigraphic evaluation from patients with
nonviable myocardium in the zone of the infarct-related
vessel.
Serial thallium-20t scintigraphy using separate injec-
tions of thallium-20t. Another approach to myocardial
thallium-20l scintigraphy in patients undergoing thrombo-
lytic therapy is to administer two separate intravenous thal-
lium injections before and 24 hours or later after treatment.
By delaying the second imaging procedure to 24 hours, one
might avoid the trapping of thallium in the infarct region
during the hyperemic phase that immediately follows re-
perfusion. Several groups of investigators have utilized this
approach. Schwarz et al. (18) performed rest thallium-20 I
scintigraphy before and 24 hours after treatment in patients
receiving intravenous followed by intracoronary streptoki-
nase. The regional ejection fraction was serially measured
up to 4 weeks after thrombolytic therapy. The improvement
in thallium defect size was greatest in those patients who
had successful recanalization and a peak serum creatine
kinase (CK) level of less than 1,000 IU. In patients who
had successful recanalization but whose CK level rose to
more than 1,000 IU, the improvement in defect size was
significantly less. Patients with unsuccessful recanalization
had no change in the extent of thallium perfusion abnor-
malities at 24 hours. Regional ejection fraction was im-
proved only in the patients with the greatest reduction in
the thallium defect size who experienced successful reftow.
Schuler et al. (19) studied 21 patients with acute myo-
cardial infarction undergoing thrombolytic therapy using the
seven-pinhole thallium tomographic technique before, I hour
(redistribution) and 24 hours (second thallium injection)
after the intervention. In patients with successful recanali-
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improved early mortality in the Western Collaborative Study
in streptokinase-treated patients is unclear.
depression and angina for prognostication. Those patients
who have significant redistribution in the supply region of
the infarct-related vessel would be candidates for coronary
arteriography with a view toward angioplasty or surgical
revascularization (Fig. 4) . This might be particularly indi-
cated in patients who also demonstrate exercise-induced
angina on the submaximal stress test. Certainly, if a mul-
tivessel disease thallium-20I scan pattern with ischemia in
the infarct region and in remote myocardium (multiple thal-
lium defects) is demonstrated, such patients would be can-
didates for angiography and subsequent revascularization
(Fig. 4). Asymptomatic patients with either single or mul-
tivessel disease who have no evidence for exercise-induced
ischemia or thallium redistribution on the predischarge ex-
ercise scintigram would probably not require angioplasty or
bypass surgery. This is irrespective of whether the infarct-
related vessel was patent or occluded.
Melin et al. (23) performed thallium-20 I scintigraphy at
rest before acute administration of intracoronary streptoki-
nase, as well as at rest and during stress 5 to 6 weeks after
acute myocardial infarction. The myocardial defect score
significantly improved only in patients who manifested re-
canalization of the infarct-related artery. The magnitude of
exercise-induced perfusion abnormalities was significantly
greater in patients in the streptokinase group compared with
those in the control group. The perfusion defect during
exercise was larger in patients with incomplete obstruction
than in patients with complete obstruction. Thus, in this
study, patients treated with streptokinase demonstrated scin-
tigraphic improvement at rest compared with results before
treatment, but had more exercise-induced ischemia that was
related to incomplete coronary obstruction and presence of
viable myocardium. Fung et al. (24) reported a significantly
greater prevalence of exercise-induced periinfarction isch-
emia on submaximal exercise thallium-201 single photon
emission computed tomography in patients who had intra-
coronary streptokinase (60%) compared with patients who
had emergency angioplasty (9 9(;) within 12 hours of the
onset of symptoms (Fig. 5 ). All patients who developed
periinfarct ischemia had 50% or more residual stenosis of
the infarct-related vessel.
Infarct volume measured by SPECT thallium-201 im-
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Figure 5. Relation between residual stenosis of the infarct-related
vessel and presence or absenceof periinfarct ischemia on thallium
tomography in patients who underwent emergent coronary angio-
plasty (PTeA) or intracoronary streptokinase (STK) therapy. (Re-
printed with permission from Fung et al. [24].)
Predischarge Exercise
Thallium-20t Scintigraphy
Patients with acute myocardial infarction who receive
intravenous thrombolytic therapy are candidates for predis-
charge exercise thallium-201 scintigraphy for risk stratifi-
cation and detection of residual ischemia. Studies (21,22)
in patients not undergoing thrombolytic therapy indicate that
the extent of perfusion abnormalities. particularly of the
redistribution type, is a significant predictor of subsequent
ischemic events. Thallium scintigraphic variables suggest-
ing underlying high risk coronary artery disease are more
sensitive than the exercise test variables of ST segment
Figure 6. Anterior view thallium-201 images
before streptokinase (A) and 10days after strep-
tokinase (8 and C ) thrombolysis in a patient
presenting with an evolving anterior myocardial
infarction. The prestreptokinase image demon-
stratesextensive apical and inferior thallium de-
fects. The initial image at rest on day 10 (8) is
normal; however, the 4 hour redistribution im-
age (C) demonstrates the pattern of reverse re-
distribution in the apical and distal inferior re-
gions. (Reprinted with permission from Weiss
et aI. [26].)
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aging at 4 weeks after onset in patients with a first myo-
cardial infarction who underwent intracoronary thrombol-
ysis correlated well with accumulated CK-MB release (25).
Thus, this tomographic approach appears promising for the
noninvasive assessment of infarct size after thrombolysis
and could serve as an important research tool.
Reverse Redistribution of Thallium-20l
Weiss et al. (26) reported that 75O/c of patients who undergo
streptokinase therapy demonstrate the reverse redistribution
pattern on day 10 after admission, Reverse redistribution is
defined as a perfusion defect that appears for the first time,
or becomes more evident on a delayed rather than on an
early image. Streptokinase-treated patients showing this
phenomenon all had patency of the infarct-related artery, a
marked improvement in rest thallium defect size from day
I to day 10 and normal or near normal wall motion. The
reverse redistribution was due to faster thallium washout in
the region with reverse redistribution compared with the
contralateral normal zone. Figure 6 is an example of "re-
verse" redistribution in one of the patients described in that
study. The authors (26) concluded that this suggested the
presence of nontransmural myocardial infarction with a pat-
ent infarct-related coronary artery, The higher than normal
washout from the ischemic zone indicated hyperemia in the
subepicardial region at the time of thallium administration.
Thallium from the subepicardium washed out more rapidly.
yielding a defect on the delayed image attributed to the
presence of subendocardial scar.
Summary: Clinical Applications
Myocardial perfusion imaging is a potentially useful non-
invasive technique to evaluate patients with acute myo-
cardial infarction undergoing intracoronary or intravenous
thrombolytic therapy. Using either quantitative planar im-
aging techniques or SPECT, the extent of underperfused
myocardium can be serially evaluated. This can be under-
taken utilizing the redistribution technique in which thallium
is given during the occlusion phase and redistribution mon-
itored after reflow. The magnitude of delayed redistribution
of thallium correlates with the amount of myocardial salvage
and subsequent degree of functional improvement. Defects
that remain persistent after intravenous or intracoronary
thrombolysis suggest that the infarct related artery is still
occluded or that reflow to irreversibly injured myocardium
has occurred. However, some persistent defects represent
severe ischemia and not substantial necrosis.
Another scintigraphic approach to evaluating patients
undergoing thrombolytic therapy entails repeat serial im-
aging at rest which can be undertaken from 24 hours to 10
days after treatment. Again, when rest imaging is carried
out 24 hours after thrombolytic therapy, the degree of thal-
lium uptake in the reperfused zone is proportional to the
amount of viable myocardium in the distribution of the
infarct-related vessel. Reported studies have demonstrated
that continued improvement in thallium uptake can be ex-
pected up to 3 months after thrombolysis. Reverse redis-
tribution may be observed and suggests persistence of epi-
cardial hyperemia and the presence of subendocardial necrosis.
Finally, if intracoronary thrombolytic therapy with or with-
out coronary angioplasty is to be carried out, intracoronary
thallium administration could be employed to qualitatively
evaluate the success of reflow. However, if thallium is ad-
ministered very soon after recanalization by either the intra-
coronary or intravenous route, the degree of thallium uptake
will overestimate the amount of myocardial salvage because
the initial uptake of the tracer is proportional to the hyper-
emic flow present.
Exercise thallium-20J scintigraphy should be useful in
estimating the degree of residual jeopardized but viable
myocardium in the perfusion zone of the infarct-related ves-
sel and in areas remote from the infarct. Whether the ad-
dition of perfusion imaging to conventional electrocardio-
graphic stress testing will be helpful in assessing the
advisability of performing further coronary angioplasty or
bypass surgery in such patients remains to be investigated.
Certainly, the presence of multiple redistribution defects on
exercise scintigraphy would influence the decision to be
more aggressive with respect to early revascularization to
prevent reinfarction or other ischemic events.
Limitations of Thallium Scintigraphy
There are several important limitations to thallium im-
aging. Great attention must be paid to good techniques in
image acquisition and processing. Many image artifacts and
variants of normal may be mistaken for defects. Redistri-
bution can best be assessed utilizing computer processing
for quantitation of myocardial uptake and washout of thal-
lium. Absolute blood flow cannot be quantitated with thal-
lium imaging in the manner accomplished using positron
scintigraphy and rubidium-82 (27). Only relative abnor-
malities in perfusion can be detected. There are limitations
to accurately quantitating infarct size by thallium imaging
although the SPECT approach may become superior to planar
imaging in this respect. New technetium-99m-labeled ison-
itrile agents that hold promise for imaging in humans are
being investigated (28). Many of the technical drawbacks
associated with thallium imaging would be overcome with
a technetium-99m-labeled perfusion agent that was also
taken up by the myocardium in proportion to blood flow.
I am appreciative of the assistance rendered by Elizabeth Howk in preparing
this manuscript.
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